Butanamide,2-(dimethylamino)-N-[11-hydroxy-3-(1-methylethyl)-5,8-dioxo-7-(phenylmethyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-3-methyl-(9CI) (10233-40-6)

Identification
Name:	Butanamide,2-(dimethylamino)-N-[11-hydroxy-3-(1-methylethyl)-5,8-dioxo-7-(phenylmethyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-3-methyl-(9CI)
Synonyms:	Butyramide,N-(7-benzyl-11-hydroxy-3-isopropyl-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl)-2-(dimethylamino)-3-methyl-(8CI); Pandaminine (7CI); 2-Oxa-6,9-diazabicyclo[10.2.2]hexadecane, butanamidederiv.
CAS:	10233-40-6
Molecular Formula:	C30H42 N4 O5
Molecular Structure:
Properties
Safety Data

Other Product

Benzenepropanamide, a-(dimethylamino)-N-[11-methoxy-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[(3S,4S,7S,11R)-11-hydroxy-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-,(aS)-
Benzenepropanamide,R-(dimethylamino)-N- [11-hydroxy-3-(1-methylethyl)-7-(1-methylpropyl)- 5,8-dioxo-2-oxa-6,9-diazabicyclo- [10.2.2]hexadeca-12,14,15-trien-4-yl]-
Pentanamide,2-(dimethylamino)-N-[(3S,4S,7S,11R)-11-hydroxy-3-(1-methylethyl)-5,8-dioxo-7-(phenylmethyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-3-methyl-,(2R,3R)-
Pentanamide,2-(dimethylamino)-N-[11-hydroxy-7-(1H-indol-3-ylmethyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-3-methyl-(9CI)
(2S)-2-Dimethylamino-N-[(3R,4S,7S)-5,8-dioxo-3-phenyl-7-phenylmethyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14(1),15-trien-4-yl]-3-methylbutanamide
2-Dimethylamino-N-[7-(hydroxyphenylmethyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),12,15-trien-4-yl]-3-methylpentanamide
N-[7-Benzoyl-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),12,15-trien-4-yl]-2-(dimethylamino)-3-methylpentanamide
Butanamide,2-(dimethylamino)-N-[7-[(4-hydroxyphenyl)methyl]-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-3-methyl-(9CI)
(αS)-N-[(3R,4R,7R)-7-[(S)-(Acetyloxy)phenylmethyl]-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetren-4-yl]-α-(dimethylamino)benzenepropanamide
Butanamide,2-(dimethylamino)-3-hydroxy-N- [7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2- oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,- 15-tetraen-4-yl]-
Butanamide,2-(dimethylamino)-3-methyl-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-
Pentanamide,2-(dimethylamino)-3-methyl-N- [7-(1-methylethyl)-5,8-dioxo-3-phenyl-2- oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,- 15-tetraen-4-yl]-
Benzenepropanamide, a-(dimethylamino)-N-[7-(1-hydroxy-2-methylpropyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
(2S)-2-Dimethylamino-N-[(3R,4S,7S)-5,8-dioxo-3-phenyl-7-phenylmethyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]-3-methylbutanamide
Pentanamide,2-(dimethylamino)-N-[7-(hydroxyphenylmethyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-3-methyl-(9CI)
(2S,3R)-2-Dimethylamino-3-methyl-N-[(3R,4S,7S)-7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14(1),15-trien-4-yl]pentanamide
N-[(3S,4S,7S,10Z)-7-benzyl-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-1-methyl-L-prolinamide
1H-Indole-3-propanamide,a-(dimethylamino)-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[3-(1-methylethyl)-7-(1-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)